28 days is the FDA prerequisite for producers of multi-use vials to prove their bacteriostatic maintains efficacy. This minimal requirement becomes the de facto regular. Tom writes about GLP-1 protocols for the reason that he couldn't come across obvious responses when he necessary them. Immediately after months of digging via scientific trials,